Tuesday broker round-up - UPDATE

AstraZeneca: Panmure Gordon keeps buy rating and 3,600p target.Bellway: Credit Suisse maintains outperform rating.BG Group: Nomura raises target from 1,865p to 1,950p, buy rating kept.Computacenter: Panmure Gordon ups target from 490p to 501p, buy rating unchanged.Hays: Credit Suisse ups target from 80p to 96p, outperform rating kept.Inchcape: Panmure Gordon reiterates hold recommendation and 372p target; Numis downgrades from buy to hold, target left at 390p.Inmarsat: Citi downgrades from neutral to sell, target cut from 480p to 410p.Interserve: UBS ups target from 225p to 260p, sell rating unchanged.JD Wetherspoon: UBS cuts target from 460p to 440p, buy rating unchanged.Lloyds: WestLB downgrades from buy to add, target cut from 42p to 41p.Meggitt: Credit Suisse reiterates underperform rating and 330p target.Persimmon: Credit Suisse maintains outperform rating.Premier Farnell: Shore Capital upgrades from sell to hold.Premier Foods: Panmure Gordon hikes target from 2p to 6p, but maintains sell rating.Royal Bank of Scotland: Credit Suisse reiterates neutral and 22p target.Sage Group: Goldman Sachs upgrades from sell to neutral, target raised from 330p to 345p.Schroders: Credit Suisse downgrades from neutral to underperform, target lifted from 1,390p to 1,550p.Smiths Group: Credit Suisse reiterates outperform rating and 1,200p target.Standard Life: Panmure Gordon downgrades from buy to hold, target left at 240p.SThree: Credit Suisse raises target from 270p to 345p, outperform rating kept.Taylor Wimpey: Credit Suisse maintains outperform rating.UNITE Group: Bank of America Merrill Lynch upgrades from neutral to buy, target lifted from 175p to 240p. Wetherspoon (J.D) Astrazeneca Lloyds Schroders Hays Sage Group Premier Foods Bellway Inchcape Computacenter Smiths Group Persimmon Taylor Wimpey Unite